Sodium-glucose cotransporter-2 inhibitors and fractures in type 2 diabetes mellitus

被引：0
|
作者：
Pavlicek, Vojtech [1 ]
机构：
[1] Kantonsspital Munsterlingen, Med Klin, Endokrinol Diabetol & Klin Ernahrung, Spitalcampus 1, CH-8596 Munsterlingen, Switzerland
来源：
DIABETOLOGE | 2022年 / 18卷 / 02期
关键词：
D O I：
10.1007/s11428-022-00858-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：198 / 199
页数：2
相关论文
共 50 条
  • [41] RE: Gout and sodium-glucose cotransporter-2 inhibitors
    Lund, Lars Christian
    Hojlund, Mikkel
    Henriksen, Daniel Pilsgaard
    Hallas, Jesper
    Kristensen, Kasper Bruun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 114 - 115
  • [42] Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes
    Zhuo, Min
    Hawley, Chelsea E.
    Paik, Julie M.
    Bessette, Lily G.
    Wexler, Deborah J.
    Kim, Dae H.
    Tong, Angela Y.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JAMA NETWORK OPEN, 2021, 4 (10)
  • [43] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
    Abrahami, Devin
    Douros, Antonios
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (09) : E150 - E152
  • [44] Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
    Shapiro, Samantha B.
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (05) : 1365 - 1370
  • [45] Sodium-glucose cotransporter-2 inhibitors and risk for genitourinary infections in older adults with type 2 diabetes
    Varshney, Navya
    Billups, Sarah J.
    Saseen, Joseph J.
    Fixen, Cy W.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2021, 12
  • [46] Heterogenous effects of sodium-glucose cotransporter-2 inhibitors on nephrolithiasis in older adults with type 2 diabetes
    Li, Yujia
    Shao, Hui
    Guo, Yi
    Zhang, Yongkang
    Fonseca, Vivian
    Shi, Lizheng
    Bian, Jiang
    Winterstein, Almut G.
    Guo, Serena Jingchuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 12 - 13
  • [47] Renal effects of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and renal impairment
    Weir, Matthew R.
    POSTGRADUATE MEDICINE, 2019, : 367 - 375
  • [48] Sodium-glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients With Type 2 Diabetes
    Bea, Sungho
    Jeong, Han Eol
    Kim, Jae Hyeon
    Yu, Oriana Hy
    Azoulay, Laurent
    Shin, Ju-Young
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (13) : 3451 - +
  • [49] EFFECTS OF ADDING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS TO STANDARD CARE IN PATIENTS WITH TYPE 2 DIABETES
    Sharma, Abhishek
    Kamran, Haroon
    Goel, Sunny
    Mukherjee, Debabrata
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (03) : 734 - 735
  • [50] Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-glucose Cotransporter-2 Inhibitors - A Case Series
    Sharma, Purva V.
    Jobanputra, Yash B.
    Lewin, Karen
    Bagatell, Stuart
    Lichtstein, Daniel M.
    REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (02) : 156 - 160
12345